Drug Detail:Mipomersen (Mipomersen [ mye-poe-mer-sen ])
Drug Class: Miscellaneous antihyperlipidemic agents
Mipomersen Levels and Effects while Breastfeeding
Summary of Use during Lactation
Mipomersen marketing has been discontinued in the United States. No relevant published information exists with the use of mipomersen during breastfeeding. Because of a concern with disruption of infant lipid metabolism, mipomersen should not be used during breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Cholestyramine, Colesevelam, Colestipol
Substance Identification
Substance Name
Mipomersen
CAS Registry Number
1000120-98-8
Drug Class
Breast Feeding
Lactation
Milk, Human
Anticholesteremic Agents
Antilipemic Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification